Oxford’s RH5.1/Matrix‑M vaccine trial confirms effective blood stage malaria vaccine safety and high efficacy in young children.
D
Enjoy Unlimited Digital Access
Read trusted, award-winning journalism.
Just $2 for 6 months.
Already a subscriber? Log in
